|
Adams-Stokes Syndrome
|
D000219 |
[A condition of fainting spells caused by heart block, often an atrioventricular block, that leads to BRADYCARDIA and drop in CARDIAC OUTPUT. When the cardiac output becomes too low, the patient faints (SYNCOPE). In some cases, the syncope attacks are transient and in others cases repetitive and persistent.
] |
|
Adansonia
|
D035162 |
[A plant genus of the family BOMBACACEAE that is used for FOOD and MEDICINE, TRADITIONAL.
] |
|
Adapalene
|
D000068816 |
[A naphthalene derivative that has specificity for RETINOIC ACID RECEPTORS. It is used as a DERMATOLOGIC AGENT for the treatment of ACNE.
] |
|
Adapalene, Benzoyl Peroxide Drug Combination
|
D000068801 |
[A pharmaceutical preparation of adapalene and benzoyl peroxide that is used as a DERMATOLOGIC AGENT for the topical treatment of ACNE.
] |
|
Adaptation, Biological
|
D000220 |
[Changes in biological features that help an organism cope with its ENVIRONMENT. These changes include physiological (ADAPTATION, PHYSIOLOGICAL), phenotypic and genetic changes.
] |
|
Adaptation, Ocular
|
D000221 |
[The adjustment of the eye to variations in the intensity of light. Light adaptation is the adjustment of the eye when the light threshold is increased; DARK ADAPTATION when the light is greatly reduced. (From Cline et al., Dictionary of Visual Science, 4th ed)
] |
|
Adaptation, Physiological
|
D000222 |
[The non-genetic biological changes of an organism in response to challenges in its ENVIRONMENT.
] |
|
Adaptation, Psychological
|
D000223 |
[A state of harmony between internal needs and external demands and the processes used in achieving this condition. (From APA Thesaurus of Psychological Index Terms, 8th ed)
] |
|
Adaptive Clinical Trial
|
D000076362 |
[Clinical study in which a prospectively planned opportunity is included to modify trial designs and hypotheses based on analysis of data from subjects in the study.
] |
|
Adaptive Clinical Trials as Topic
|
D000075522 |
[Works about clinical studies in which a prospectively planned opportunity is included to modify trial designs and hypotheses based on analysis of data from subjects in the study.
] |
|
Adaptive Immunity
|
D056704 |
[Protection from an infectious disease agent that is mediated by B- and T- LYMPHOCYTES following exposure to specific antigen, and characterized by IMMUNOLOGIC MEMORY. It can result from either previous infection with that agent or vaccination (IMMUNITY, ACTIVE), or transfer of antibody or lymphocytes from an immune donor (IMMUNIZATION, PASSIVE).
] |
|
Adaptor Protein Complex 1
|
D033961 |
[A clathrin adaptor protein complex primarily involved in clathrin-related transport at the TRANS-GOLGI NETWORK.
] |
|
Adaptor Protein Complex 2
|
D033962 |
[An adaptor protein complex primarily involved in the formation of clathrin-related endocytotic vesicles (ENDOSOMES) at the CELL MEMBRANE.
] |
|
Adaptor Protein Complex 3
|
D033963 |
[An adaptor protein complex found primarily on perinuclear compartments.
] |
|
Adaptor Protein Complex 4
|
D033964 |
[An adaptor protein complex involved in transport of molecules between the TRANS-GOLGI NETWORK and the endosomal-lysosomal system.
] |
|
Adaptor Protein Complex Subunits
|
D034001 |
[The subunits that make up the large, medium and small chains of adaptor proteins.
] |
|
Adaptor Protein Complex alpha Subunits
|
D033965 |
[A family of large adaptin protein subunits of approximately 100 kDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 2.
] |
|
Adaptor Protein Complex beta Subunits
|
D033966 |
[A family of large adaptin protein complex subunits of approximately 90-130 kDa in size.
] |
|
Adaptor Protein Complex delta Subunits
|
D033981 |
[A family of large adaptin protein subunits of approximately 130-kDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 3.
] |
|
Adaptor Protein Complex gamma Subunits
|
D033982 |
[A family of large adaptin protein subunits of approximately 90 KDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 1.
] |
